New Heart Failure Trials

Clinical trials focused on heart failure research, exploring new therapies and treatment strategies. Some of these trials aim to address unmet needs or build upon existing knowledge to improve heart failure management.

EMPEROR-Preserved: This trial investigated the use of empagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor, in patients with heart failure and preserved ejection fraction (HFpEF). The study assessed the potential benefits of this drug in reducing heart failure hospitalizations and improving cardiovascular outcomes in this specific patient population.

GALACTIC-HF: This global trial evaluated the efficacy and safety of omecamtiv mecarbil, a novel cardiac myosin activator, in patients with heart failure and reduced ejection fraction (HFrEF). The study aimed to determine whether this new therapy could improve cardiac function and reduce heart failure-related events.

VICTORIA: This trial investigated the use of vericiguat, a soluble guanylate cyclase stimulator, in patients with worsening chronic heart failure. The study examined the drug's potential to reduce cardiovascular death and heart failure hospitalization rates.

These trials and others are crucial in advancing the understanding of heart failure and identifying new treatment options that could potentially benefit patients in the future. It's essential to consult the latest scientific literature or clinical trial registries for updates and results.

    Related Conference of New Heart Failure Trials

    December 26-27, 2024

    28th World Cardiology Conference

    Paris, France
    February 20-21, 2025

    35th International Conference on Cardiology and Healthcare

    Amsterdam, Netherlands
    February 20-21, 2025

    14th World Congress on Cardiology

    Amsterdam, Netherlands
    February 24-25, 2025

    40th World Cardiology Conference

    London, UK
    February 27-28, 2025

    4th Global Summit on Cardiology and Cardiac Surgery

    Paris, France
    March 24-25, 2025

    14th World Heart Congress

    Paris, France
    April 16-17, 2025

    8th World Heart and Brain Conference

    Tokyo, Japan
    April 24-25, 2025

    9th Annual Heart Rhythm Conference

    Vienna, Austria
    April 28-29, 2025

    37th World Congress on Cardiology & Heart Diseases

    Frankfurt, Germany
    April 28-29, 2025

    39th World Congress on Heart Diseases

    Frankfurt, Germany
    May 19-20, 2025

    4th International Conference on Cardiology

    Rome, Italy
    May 22-23, 2025

    5th World Congress on Congestive Heart Failure & Angina

    Zurich, Switzerland
    May 26-27, 2025

    6th European Summit on Cardiology Research

    Rome, Italy
    August 11-12, 2025

    3rd International Conference on World Heart Care

    Toronto, Canada
    August 21-22, 2025

    8th Global Cardiovascular Research and Clinical Cardiology

    Vancouver, Canada
    September 08-09, 2025

    39th European Cardiology Conference

    Frankfurt, Germany
    September 22-23, 2025

    7th Annual Conference on Vascular Medicine

    Amsterdam, Netherlands

    New Heart Failure Trials Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in